# A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

> **NCT05135468** · PHASE3 · COMPLETED · sponsor: **Cutia Therapeutics（Wuxi）Co.,Ltd** · enrollment: 270 (actual)

## Conditions studied

- AGA

## Interventions

- **DRUG:** CU-40102 Spray

## Key facts

- **NCT ID:** NCT05135468
- **Lead sponsor:** Cutia Therapeutics（Wuxi）Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-06
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-05-15
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135468, "A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05135468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*